ATLANTA, March 1 /PRNewswire-FirstCall/ -- MiMedx Group, Inc. announced today that the Company received the CE Mark for its HydroFix(TM) Spine Shield device and was certified for design, development, and production of post-surgical adhesion inhibiting barriers. The HydroFix(TM) Spine Shield is indicated for use in specific locations as a cover of the spine to provide a plane of dissection during a revision surgery. The proprietary, patented, and biocompatible polyvinyl alcohol polymer (PVA) membrane may reduce the risk of injury that may be associated with anterior vertebral surgeries. By covering the spine at the surgical repair site in anterior spine surgeries, HydroFix(TM) Spine Shield creates a plane of dissection for revision surgeries.
Parker H. “Pete” Petit, Chairman, President and CEO, commented, “This is the first MiMedx Group product to receive a CE Mark for commercial sale. The Company’s strategy is focused on commercializing exciting new technologies, such as HydroFix(TM) Spine Shield, for orthopedic and other healthcare markets. Our focused development efforts include a number of advanced technology products that we plan to introduce worldwide following their progression through the clinical and regulatory clearance and approval processes .”
The Company received notification from TUV Rheinland(R) that it obtained approval to apply the CE Mark on February 12, 2010. HydroFix(TM) Spine Shield is not available in the United States.
CONTACT: Michael Senken, +1-678-384-6740
